|
Volumn 309, Issue 14, 2013, Pages 1463-1464
|
Realizing the opportunities of genomics in health care
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
B RAF KINASE;
BCR ABL PROTEIN;
CETUXIMAB;
CLOPIDOGREL;
CRIZOTINIB;
CYTOCHROME P450 2C19;
DNA;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GEFITINIB;
IMATINIB;
K RAS PROTEIN;
PANITUMUMAB;
PROBIOTIC AGENT;
TRASTUZUMAB;
VEMURAFENIB;
ACCESS TO INFORMATION;
BIOTECHNOLOGY;
BRAF GENE;
BREAST CANCER;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
CLINICAL DECISION MAKING;
COLORECTAL CANCER;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
ELECTRONIC MEDICAL RECORD;
ENTERITIS;
ERBB2 GENE;
FOOD AND DRUG ADMINISTRATION;
GENE;
GENE MUTATION;
GENETIC ANALYSIS;
GENETIC RISK;
GENETIC VARIABILITY;
GENOTYPE;
HEALTH HAZARD;
HETEROZYGOTE DETECTION;
HIGH THROUGHPUT SEQUENCING;
HUMAN;
HUMAN GENOME PROJECT;
LUNG NON SMALL CELL CANCER;
MEDICAL RESEARCH;
MELANOMA;
MICROBIAL GENETICS;
NEWBORN SCREENING;
ONCOGENE K RAS;
PATIENT CARE;
PHARMACOGENOMICS;
PREDICTION;
PRENATAL DIAGNOSIS;
PRENATAL SCREENING;
PREVENTIVE MEDICINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK ASSESSMENT;
SHORT SURVEY;
TREATMENT RESPONSE;
UNITED STATES;
|
EID: 84875955036
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.1465 Document Type: Short Survey |
Times cited : (25)
|
References (7)
|